Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07321899 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation

Study acronym: PATHFINDER
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial sites expanded: 4 → 13 locations
    • Start date changed from estimate of Aug 2026 to Sep 11, 2026
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 1 of 7 entries
  2. Recruitment opened
    • Start date: Jun 2026 to Aug 2026
    • Trial sites expanded: 0 → 4 locations
    v3
  3. Secondary endpoints: details revised at 2 of 7 entriesv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.
Trial Details
NCT Number NCT07321899
Lead Sponsor Medtronic Cardiovascular
Conditions
(from sponsor)		 Severe Tricuspid Regurgitation
Related terms Heart Valve Diseases, Tricuspid Valve Insufficiency
Enrollment 1,186 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov